Borderline personality disorder and substance use disorders: An updated review

Borderline Personality Disorder and Emotion Dysregulation

Volumn 5, Issue 1, 2018, Pages

  Trull, Timothy J ^a   Freeman, Lindsey K ^a   Vebares, Tayler J ^a   Choate, Alexandria M ^a   Helle, Ashley C ^a   Wycoff, Andrea M ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Alcohol use disorder; Borderline personality disorder; Comorbidity; Substance use disorder

Indexed keywords

EID: 85057428623     PISSN: None     EISSN: 20516673     Source Type: Journal    
DOI: 10.1186/s40479-018-0093-9     Document Type: Review

References (106)

1. Gunderson JG. Borderline personality disorder: a clinical guide. Washington, D.C.: American Psychiatric Press; 2001.
2. Leichsenring F, Leibing E, Kruse J, New AS, Leweke F. Borderline personality disorder. Lancet. 2011;377:74-84.
3. Paris J. Borderline personality disorder: a multidimensional approach. Washington DC: American Psychiatric Pub; 1994.
4. Trull TJ, Sher KJ, Minks-Brown C, Durbin J, Burr R. Borderline personality disorder and substance use disorders: a review and integration. Clin Psychol Rev. 2000;20:235-53.
5. First MB. Mutually exclusive versus co-occurring diagnostic categories: the challenge of diagnostic comorbidity. Psychopathology. 2005;38:206-10.
6. Lilienfeld SO, Waldman ID, Israel AC. A critical examination of the use of the term and concept of comorbidity in psychopathology research. Clin Psychol Sci Pract. 1994;1:71-83.
7. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.
8. Widiger TA, Trull TJ. Borderline and narcissistic personality disorders. In: Adams H, Sutker P, editors. Comprehensive handbook of psychopathology. 2nd ed. New York: Plenum; 1993. p. 371-94.
9. Lenzenweger M, Lane M, Loranger A, Kessler R. Personality disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007;62:553-64.
10. Tomko RL, Trull TJ, Wood PK, Sher KJ. Characteristics of borderline personality disorder in a community sample: comorbidity, treatment utilization, and general functioning. J Personal Disord. 2014;28(5):734-50.
11. Trull TJ, Jahng S, Tomko RL, Wood PK, Sher KJ. Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. J Personal Disord. 2010;24(4):412-26.
12. Widiger TA. Dimensional models of personality disorder. World Psychiatry. 2007;6:79-83.
13. Clark LA. Assessment and diagnosis of personality disorder: perennial issues and an emerging reconceptualization. Annu Rev Psychol. 2007;58:227-57.
14. Widiger TA, Trull TJ. Plate tectonics in the classification of personality disorder. Am Psychol. 2007;62:71-83.
15. Saulsman LM, Page AC. The five-factor model and personality disorder empirical literature: a meta-analytic review. Clin Psychol Rev. 2004;23:1055-85.
16. Kernberg O. Severe personality disorders. New Haven: Yale University Press; 1984.
17. Millon T. Disorders of personality: DSM-III Axis II. New York: Wiley; 1981.
18. Dulit RA, Fyer MR, Haas GL, Sullivan T, Frances AJ. Substance use in borderline personality disorder. Am J Psyc. 1990;147:1002-7.
19. Grilo CM, Martino S, Walker ML, Becker DF. Controlled study of psychiatric comorbidity in psychiatrically hospitalized young adults with substance use disorders. Am J Psyc. 1997;154:1305-7.
20. Littlefield AK, Sher KJ. Personality and substance use disorders. In: Sher KJ, editor. Oxford handbook of substance use disorders, vol. 1. New York: Oxford; 2016. p. 351-74.
21. Conrod P, Nikolaou K. Annual research review: on the developmental neuropsychology of substance use disorders. J Child Psychol Psychiatry. 2016;57:371-94.
22. Kwako LE, Momenan R, Litten RZ, Koob GF, Goldman D. Addictions neuroclinical assessment: a neuroscience-based framework for addictive disorders. Biol Psychiatry. 2016;80:179-89.
23. Cooper ML, Kuntsche E, Levitt A, Barber LL, Wolf S. Motivational models of substance use: a review of theory and research on motives for using alcohol, marijuana, and tobacco. In: Sher KJ, editor. The Oxford handbook of substance use disorders, vol. 1. New York: Oxford; 2016. p. 375-421.
24. Litten RZ, Ryan ML, Falk DE, Reilly M, Fertig JB, Koob GF. Heterogeneity of alcohol use disorder: understanding mechanisms to advance personalized treatment. Alc Clin Exp Res. 2015;39:579-84.
25. Trull TJ, Solhan MB, Brown WC, Tomko RL, Schaefer L, McLaughlin KD, Jahng S. Substance use disorders and personality disorders. In: Sher KJ, editor. The Oxford handbook of substance use disorders, vol. 2. New York: Oxford; 2016. p. 116-48.
26. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
27. Tadić A, Wagner S, Hoch J, Başkaya Ö, von Cube R, Skaletz C,., Dahmen N. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder. Psychopathology 2009;42:257-263.
28. Crowell SE, Beauchaine TP, Linehan MM. A biosocial developmental model of borderline personality: elaborating and extending Linehan's theory. Psychol Bull. 2009;135:495-510.
29. Gunderson JG, Fruzzetti A, Unruh B, Choi-Kain L. Competing theories of borderline personality disorder. J Personal Disord. 2018;32:148-67.
30. Bornovalova MA, Hicks BM, Iacono WG, McGue M. Longitudinal twin study of borderline personality disorder traits and substance use in adolescence: developmental change, reciprocal effects, and genetic and environmental influences. PD:TRT. 2013;4:23-32.
31. Distel MA, Trull TJ, de Moor MM, Vink JM, Geels LM, van Beek JH, et al. Borderline personality traits and substance use: genetic factors underlie the association with smoking and ever use of cannabis, but not with high alcohol consumption. J Personal Disord. 2012;26:867-79.
32. Few LR, Grant JD, Trull TJ, Statham DJ, Martin NG, Lynskey MT, Agrawal A. Genetic variation in personality traits explains genetic overlap between borderline personality features and substance use disorders. Addiction. 2014;109:2118-27.
33. Long EC, Aggen SH, Neale MC, Knudsen G, Krueger RF, South SC, et al. The association between personality disorders with alcohol use and misuse: a population-based twin study. Drug Alc Dep. 2017;174:171-80.
34. Gillespie NA, Aggen SH, Neale MC, Knudsen GP, Krueger RF, South SC, et al. Associations between personality disorders and cannabis use and cannabis use disorder: a population-based twin study. Addiction. 2018; https://doi.org/10.1111/add.14209.
35. Linehan M. Cognitive-behavioral treatment of borderline personality disorder. New York: Guilford press; 1993.
36. Lee NK, Cameron J, Jenner L. A systematic review of interventions for co-occurring substance use and borderline personality disorders. Drug Alc Rev. 2015;34:663-72.
37. Dimeff LA, Linehan MM. Dialectical behavior therapy for substance abusers. Addict Sci Clin Prac. 2008;4:39-47.
38. Grant BF, Stinson FS, Dawson DA, Chou SP, Ruan WJ, Pickering RP. Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States. Arch Gen Psychiatry. 2004;61:361-8.
39. Brady KT, Sinha R. Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. Am J Psychiatry. 2005;162:1483-93.
40. Anestis MD, Gratz KL, Bagge CL, Tull MT. The interactive role of distress tolerance and borderline personality disorder in suicide attempts among substance users in residential treatment. Compr Psychiatry. 2012;53:1208-16.
41. Bardeen JR, Dixon-Gordon KL, Tull MT, Lyons JA, Gratz KL. An investigation of the relationship between borderline personality disorder and cocaine-related attentional bias following trauma cue exposure: the moderating role of gender. Compr Psychiatry. 2014;55:113-22.
42. Bornovalova MA, Gratz KL, Daughters SB, Nick B, Delany-Brumsey A, Lynch TR, et al. A multi- modal assessment of the relationship between emotion dysregulation and borderline personality disorder among inner-city substance users in residential treatment. J Psychiatr Res. 2008;42:717-26.
43. Bottlender M, Preuss UW, Soyka M. Association of personality disorders with type a and type B alcoholics. Eur Arch Psychiatry Clin Neurosci. 2006;256:55-61.
44. Dixon-Gordon KL, Tull MT, Gratz KL. Self-injurious behaviors in posttraumatic stress disorder: an examination of potential moderators. J Affect Disord. 2014;166:359-67. https://doi.org/10.1016/j.jad.2014.05.033.
45. Dunsieth NW, Nelson EB, Brusman-Lovins LA, Holcomb JL, Beckman D, Welge JA, et al. Psychiatric and legal features of 113 men convicted of sexual offenses. J Clin Psychiatry. 2004;65:293-300.
46. Gonzalez C. Screening for personality disorder in drug and alcohol dependence. Psychiatry Res. 2014;217:121-3.
47. Gratz KL, Tull MT. The relationship between emotion dysregulation and deliberate self-harm among inpatients with substance use disorders. Cogn Ther Res. 2010;34:544-53.
48. Kopetz C, Pickover A, Magidson JF, Richards JM, Iwamoto D, Lejuez CW. Gender and social rejection as risk factors for engaging in risky sexual behavior among crack/cocaine users. Prev Sci. 2014;15:376-84.
49. Krieger DM, Benzano D, Reppold CT, Fialho PO, Pires GB, Terra MB. Personality disorder and substance related disorders: a six-month follow-up study with a Brazilian sample. J Bras Psiquiatr. 2016;65:127-34. https://doi.org/10.1590/0047-2085000000113.
50. Modestin J, Matutat B, Wurmle O. Antecedents of opioid dependence and personality dis- order: attention-deficit/hyperactivity disorder and conduct disorder. Eur Arch Psychiatry Clin Neurosci. 2001;251:42-7.
51. Preuss UW, Koller G, Bondy B, Bahlmann M, Soyka M. Impulsive traits and 5-HT2A receptor promoter polymorphism in alcohol dependents: possible association but no influence of personality disorders. Neuropsychobiology. 2001;43:186-91.
52. Ross S, Dermatis H, Levounis P, Galanter M. A comparison between dually diagnosed inpatients with and without Axis II comorbidity and the relationship to treatment outcome. Am J Drug Alcohol Abuse. 2003;29:263-79.
53. Tull MT, Gratz KL, Weiss NH. Exploring associations between borderline personality disorder, crack/cocaine dependence, gender, and risky sexual behavior among substance-dependent inpatients. Person Disord Theory Res Treatment. 2011;2:209.
54. Vergara-Moragues E, González-Saiz F, Lozano OM, García AV. Psychiatric profile of three-month retention in cocaine-dependent patients treated in a therapeutic community. J Stud Alcohol Drugs. 2013;74:452.
55. Webber TA, Kiselica AM, Arango A, Rojas E, Neale MC, Mornovalova MA. Unidirectionality between borderline personality disorder traits and psychopathology in a residential addictions sample: a short-term longitudinal study. J Personal Disord. 2015;29:755-70. https://doi.org/10.1521/pedi_2014_28_172.
56. Yang M, Liao Y, Wang Q, Chawarski MC, Hao W. Profiles of psychiatric disorders among heroin dependent individuals in Changsha, China. Drug Alcohol Depend. 2015;149:272-9. https://doi.org/10.1016/j.drugalcdep.2015.01.028.
57. Zikos E, Gill KJ, Charney DA. Personality disorders among alcoholic outpatients: prevalence and course in treatment. Can J Psychiatr. 2010;55:65-73.
58. Ball SA. Comparing individual therapies for personality disordered opioid dependent patients. J Personal Disord. 2007;21:305-21.
59. Ball SA, Cecero JJ. Addicted patients with personality disorders: traits, schemas, and presenting problems. J Personal Disord. 2001;15:72-83.
60. Barral C, Daigre C, Bachiller D, Calvo N, Ros-Cucurull E, Gancedo B, Grau-López L, Ferrer M, Casas M, Roncero C. Severity factors associated with borderline personality disorders among misusers in an outpatient sample in Spain. J Addict Dis. 2017;36:93-6.
61. Becker DF, Añez LM, Paris M, Grilo CM. Exploratory factor analysis of borderline personality disorder criteria in monolingual Hispanic outpatients with substance use disorders. Psychiatry Res. 2010;178:305-8.
62. Casadio P, Olivoni D, Ferrari B, Pintori C, Speranza E, Bosi M, Belli V, Baruzzi L, Pantieri P, Ragazzini G, Rivola F, Atti AR. Personality disorders in addiction outpatients: prevalence and effects on psychosocial functioning. Subst Abuse. 2014;8:17.
63. Dammann G, Gerber H, Denier N, Schmid O, Huber C, Riecher-Rossler A, et al. The influence of comorbid personality disorder on patients in heroin-assisted treatment: Pilot data on clinical outcome. Heroin Addict Relat Clin Prob. 2017; in press
64. DeMarce JM, Lash SJ, Parker JD, Burke RS, Grambow SC. Validity of the structured clinical interview for DSM-IV among veterans seeking treatment for substance use disorders. Int J Ment Heal Addict. 2013;11:546-56.
65. Echeburua E, De Medina RB, Aizpiri J. Alcoholism and personality disorders: an exploratory study. Alcohol Alcoholism. 2005;40:323-6.
66. Echeburua E, De Medina RB, Aizpiri J. Comorbidity of alcohol dependence and personality disorders: a comparative study. Alcohol Alcoholism. 2007;42:618-22.
67. Hunter-Reel D, Epstein EE, McCrady BS, Eddie D. Personality disorders and the prediction of alcohol use outcomes for women: dimensional versus categorical classification. Addict Res Theory. 2014;22:176-80. https://doi.org/10.3109/16066359.2013.793314.
68. Kidorf M, King VL, Peirce J, Gandotra N, Ghazarian S, Brooner RK. Substance use and response to psychiatric treatment in methadone-treated outpatients with comorbid psychiatric disorder. J Subst Abus Treat. 2015;51:64-9. https://doi.org/10.1016/j.jsat.2014.10.012.
69. Kok T, de Haan H, Wieske E, de Weert G, de Jong C. Screening for personality disorders in outpatient substance use disorder patients. Eur J Psychol Assess. 2017;33:166-72. https://doi.org/10.1027/1015-5759/a000282.
70. Palmer NB, Salcedo J, Miller AL, Winiarski M, Arno P. Psychiatric and social barriers to HIV medication adherence in a triply diagnosed methadone population. AIDS Patient Care STDs. 2003;17:635-44.
71. Ralevski E, Ball S, Nich C, Limoncelli D, Petrakis I. The impact of personality disorders on alcohol-use outcomes in a pharmacotherapy trial for alcohol dependence and comorbid Axis I disorders. Am J Addict. 2007;16:443-9.
72. Zimmerman M, Rothschild L, Chelminski I. The prevalence of DSM-IV personality disorders in psychiatric outpatients. Am J Psychiatr. 2005;162:1911-8.
73. Chapman AL, Cellucci T. The role of antisocial and borderline personality features in substance dependence among incarcerated females. Addict Behav. 2007;32:1131-45.
74. Grella CE, Greenwell L, Prendergast M, Sacks S, Melnick G. Diagnostic profiles of offenders in substance abuse treatment programs. Behav Sci Law. 2008;26:369-88.
75. Mir J, Kastner S, Priebe S, Konrad N, Strohle A, Mundt AP. Treating substance abuse is not enough: comorbidities in consecutively admitted female prisoners. Addict Behav. 2015;46:25-30. https://doi.org/10.1016/j.addbeh.2015.02.016.
76. Fenton MC, Keyes K, Geier T, Greenstein E, Skodol A, Krueger B, et al. Psychiatric comorbidity and the persistence of drug use disorders in the United States. Addiction. 2012;107:599-609.
77. Whitbeck LB, Armenta BE, Welch-Lazoritz ML. Borderline personality disorder and axis I psychiatric and substance use disorders among women experiencing homelessness in three U.S. cities. Soc Psychiatry Psychiatr Epidemiol. 2015;50:1285-91.
78. Comín M, Redondo S, Daigre C, Grau-López L, Casas M, Roncero C. Clinical differences between cocaine-dependent patients with and without antisocial personality disorder. Psychiatry Res. 2016;246:587-92.
79. Daigre C, Rodríguez-Cintas L, Tarifa N, Rodríguez-Martos L, Grau-López L, Berenguer M,., Roncero C. History of sexual, emotional or physical abuse and psychiatric comorbidity in substance-dependent patients. Psychiatry Res 2015;229:743-749.
80. Hasin D, Samet S, Nunes E, Meydan J, Matseoane K, Waxman R. Diagnosis of comorbid psychiatric disorders in substance users assessed with the psychiatric research interview for substance and mental disorders for DSM-IV. Am J Psychiatr. 2006;163:689-96.
81. Malik K, Chand PK, Marimuthu P, Suman LN. Addiction severity and comorbidity among women with alcohol use disorders: a hospital-based study from India. Asian J Psychiatr. 2017;28:67-72. https://doi.org/10.1016/j.ajp.2017.03.028.
82. Ross J, Teesson M, Darke S, Lynskey M, Ali R, Ritter A, et al. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS). Drug Alcohol Rev. 2005;24:411-8.
83. Rubio G, Jimenez M, Rodriguez-Jimenez R, Martinez I, Iribarren MM, Jimenez-Arriero MA, et al. Varieties of impulsivity in males with alcohol dependence: the role of cluster-B personality disorder. Alcohol Clin Exp Res. 2007;31:1826-32.
84. Torrens M, Serrano D, Astals M, Perez-Dominguez G, Martin-Santos R. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the psychiatric research interview for substance and mental disorders and the structured clinical interview for DSM-IV. Am J Psychiatr. 2004;161:1231-7.
85. Wapp M, van de Glind G, van Emmerik-van Oortmerssen K, Dom G, Verspreet S, Jan Carpentier P,., Moggi F. Risk factors for borderline personality disorder in treatment seeking patients with a substance use disorder: An international multicenter study. Eur Addict Res 2015;21:188-194. doi: https://doi.org/10.1159/000371724.
86. Asnaani A, Chelminski I, Young D, Zimmerman M. Heterogeneity of borderline personality disorder: do the number of criteria met make a difference? J Personal Disord. 2007;21:615-25.
87. Chen EY, Brown MZ, Lo TTY, Linehan MM. Sexually transmitted disease rates and high-risk sexual behaviors in borderline personality disorder versus borderline personality disorder with substance use disorder. J Nerv Ment Dis. 2007;195:125-9.
88. Comtois KA, Russo J, Snowden M, Srebnik D, Ries R, Roy-Byrne P. Factors associated with high use of public mental health services by persons with borderline personality disorder. Psychiatr Serv. 2003;54:1149-54.
89. Frias A, Navarro S, Palma C, Farriols N, Aliaga F, Salvador A,., Solves L. Early maladaptive schemas associated with dimensional and categorical psychopathology in patients with borderline personality disorder. Clin Psychol Psychother 2017;1-12. doi: https://doi.org/10.1002/cpp.2123
90. Hidalgo-Mazzei D, Walsh E, Rosenstein L, Zimmerman M. Comorbid bipolar disorder and borderline personality disorder and substance use disorder. J Nerv Ment Dis. 2015;203:54-7. https://doi.org/10.1097/NMD.0000000000000235.
91. Johnson DM, Shea MT, Yen S, Battle CL, Zlotnick C, Sanislow CA, et al. Gender differences in borderline personality disorder: findings from the collaborative longitudinal personality disorders study. Compr Psychiatry. 2003;44:284-92.
92. Lane SP, Carpenter RW, Sher KJ, Trull TJ. Alcohol craving and consumption in borderline personality disorder: when, where, and with whom. Clin Psychol Sci. 2016;4:775-92. https://doi.org/10.1177/2167702615616132.
93. Maraz A, Ando B, Rigo P, Harmatta J, Takach G, Zalka Z,., Demetrovics Z. The two-faceted nature of impulsivity in patients with borderline personality disorder and substance use disorder. Drug Alcohol Dependence 2016;163:48-54. doi: https://doi.org/10.1016/j.drugalcdep.2016.03.015.
94. Neacsiu AD, Herr NR, Fang CM, Rodriguez MA, Rosenthal MZ. Identity disturbance and problems with emotion regulation are related constructs across diagnoses. J Clin Psychol. 2015;71:346-61.
95. Perroud N, Zewdie S, Stenz L, Adouan W, Bavamian S, Prada P,., Paoloni-Giacobino A. Methylation of serotonin receptor 3A in ADHD, borderline personality, and bipolar disorders: link with severity of the disorders and childhood maltreatment. Depress Anxiety 2016;33:45-55.
96. Riihimäki K, Vuorilehto M, Isometsä E. Borderline personality disorder among primary care depressive patients: a five-year study. J Affect Disord. 2013;155:303-6.
97. Turner BJ, Dixon-Gordon KL, Austin SB, Rodriguez MA, Rosenthal MZ, Chapman AL. Non-suicidal self-injury with and without borderline personality disorder: differences in self-injury and diagnostic comorbidity. Psychiatry Res. 2015;230:28-35.
98. Welch SS, Linehan MM. High-risk situations associated with parasuicide and drug use in borderline personality disorder. J Personal Disord. 2002;16:561-9.
99. Wetterborg D, Langstrom N, Andersson G, Enebrink P. Borderline personality disorder: prevalence and psychiatric comorbidity among male offenders on probation in Sweden. Compr Psychiatry. 2015;62:63-70. https://doi.org/10.1016/j.comppsych.2015.06.014.
100. Baschnagel JS, Coffey SF, Hawk LW, Jr., Schumacher JA, Holloman G. Psychophysiological assessment of emotional processing in patients with borderline personality disorder with and without comorbid substance use. Person Disord Theory Res Treat 2013;4:203.
101. Carpenter RW, Wood PK, Trull TJ. Comorbidity of borderline personality disorder and lifetime substance use disorders in a nationally representative sample. J Person Disord. 2016;30:336-50. https://doi.org/10.1521/pedi_2015_29_197.
102. Widom CS, Czaja SJ, Paris J. A prospective investigation of borderline personality disorder in abused and neglected children followed up into adulthood. J Personal Disord. 2009;23:433-46.
103. Barone L, Fossati A, Guiducci V. Attachment mental states and inferred pathways of development in borderline personality disorder: a study using the adult attachment interview. Attach Hum Dev. 2011;13:451-69.
104. Berenson KR, Gregory WE, Glaser E, Romirowsky A, Rafaeli E, Yang X, Downey G. Impulsivity, rejections sensitivity, and reactions to stressors in borderline personality disorder. Cogn Therapy Res. 2016;40:510-21. https://doi.org/10.1007/s10608-015-9752-y.
105. McCormick B, Blum N, Hansel R, Franklin JA, St. John D, Pfohl B, et al. Relationship of sex to symptom severity, psychiatric comorbidity, and health care utilization in 163 subjects with borderline personality disorder. Compr Psychiatry. 2007;48:406-12.
106. Walter M, Gunderson JG, Zanarini MC, Sanislow CA, Grilo CM, McGlashan TH,., Skodol AE. New onsets of substance use disorders in borderline personality disorder over 7 years of follow-ups: findings from the collaborative longitudinal personality disorders study. Addiction 2009;104:97-103.